Targeting the non-structural proteins of hepatitis C virus: beyond hepatitis C virus protease and polymerase

Author： Holler Tod P Parkinson Tanya Pryde David C

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.4, Iss.3, 2009-03, pp. : 293-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapies for Hepatitis C Infection: Targeting the Non-Structural Proteins of HCV

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 1, Iss. 2, 2002-04 ,pp. : 163-176

Bentham Science Publishers

Access to resources Recommend Favorite

Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection

By Sheldon Julie Barreiro Pablo Vincent Vincent

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1171-1181

Informa Healthcare

Access to resources Recommend Favorite

Peptidic Inhibitors of the Hepatitis C Virus Serine Protease within Non- Structural Protein 3

Current Pharmaceutical Design, Vol. 8, Iss. 28, 2002-12 ,pp. : 2533-2540

Bentham Science Publishers

Access to resources Recommend Favorite

ABT-450: A Novel Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Current Medicinal Chemistry, Vol. 21, Iss. 28, 2014-09 ,pp. : 3261-3270

Bentham Science Publishers

Access to resources Recommend Favorite

Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 267-272

Informa Healthcare

Access to resources Recommend Favorite